List view / Grid view

Cezary Statuch (Head of Medical Affairs International and Japan at Alexion Pharmaceuticals)

 

article

Why patient-centricity is essential to accelerate rare disease clinical research

20 May 2024 | By

There is an urgent need for novel treatment options for people living with rare diseases, but carrying out clinical research in this field is notoriously difficult. As Clinical Trials Day approaches, Cezary Statuch, Head of Medical Affairs International and Japan at Alexion Pharmaceuticals, highlights how adopting patient-centric approaches can help…